Publications by authors named "A M Lebech"
Background: Brain health may be impaired years after hospitalization for critical illness, and similar impairments occur after hospitalization for COVID-19. However, it remains unclear which patients are most likely to experience long-term brain health consequences and whether these adverse events differ between non-COVID critical illness and COVID-19.
Methods: In a prospective observational study, we enrolled patients hospitalized for (1) non-COVID critical illness (pneumonia, myocardial infarction, or ICU-requiring conditions) or for (2) COVID-19, from March 2020 to June 2021.
Background: It has been suggested that neuroborreliosis in children can manifest as psychiatric neurodevelopmental disorders or cause long-term neurodevelopmental sequelae. However, previous studies were limited by size and design.
Methods: We performed a nationwide, population-based, matched cohort study in Denmark between 1995 and 2021.
Objective: To investigate the use of non-barrier contraceptives among women with HIV (WWH) compared to women from the general population (WGP) in Denmark.
Design: Nationwide population-based matched cohort study.
Methods: We included WWH aged 16-50, treated at an HIV specialized clinic, and included in The Danish HIV Cohort Study between 1995-2021 and an age-matched comparison cohort of WGP.
Article Synopsis
- The study examined the relationship between bipolar disorders and the risk of HIV infection, as well as the risk of bipolar disorders in people with HIV (PWH) and their siblings.
- It used data from a large Danish population-based study, analyzing information from over 5,000 PWH and more than 53,000 matched individuals from the general population.
- Results showed that bipolar disorder increases the risk of HIV infection significantly, especially among injection drug users, and that PWH have a notably higher risk of developing bipolar disorder, particularly in the first two years after diagnosis.
Objectives: To better understand the Lyme borreliosis (LB) burden in Europe, we aimed to estimate the incidence of symptomatic Borrelia burgdorferi sensu lato (Bbsl) infections after adjusting public health LB surveillance data for under-detection of symptomatic Bbsl infections.
Methods: Data from seroprevalence studies and estimates of the symptomatic proportion and duration of antibody detection in Bbsl-infected individuals, derived from reviews of the published literature, were used to adjust public health LB surveillance data to estimate the incidence of symptomatic Bbsl infection in nine European countries from 2018 to 2022.
Results: The prevalence of anti-Bbsl antibodies ranged from 2.